Vimpat

In the US, Vimpat (lacosamide systemic) is a member of the drug class miscellaneous anticonvulsants and is used to treat Seizures.

US matches:

• Vimpat


• Vimpat Tablets


• Vimpat Intravenous

UK matches:

• Vimpat 50 mg, 100 mg, 150 mg & 200 mg film-coated tablets, 15 mg/ml syrup and 10 mg/ml solution for infusion (SPC)

Ingredient matches for Vimpat

Lacosamide

Lacosamide is reported as an ingredient of Vimpat in the following countries:

• Australia


• Austria


• France


• Germany


• Spain


• Sweden


• Switzerland


• United Kingdom


• United States

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.